Search This Blog

Tuesday, August 17, 2021

FDA Grants Accelerated Approval Of GSK's JEMPERLI; Milestone for AnaptysBio

 AnaptysBio earns $20M payment.

https://www.benzinga.com/general/biotech/21/08/22545736/anaptysbiofda-grants-accelerated-approval-of-gsks-jemperli-which-was-generated-by-anaptysbio-co-h

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.